US 7820671
Peptidomimetic protease inhibitors
granted A61KA61K38/07A61K38/08
Quick answer
US patent 7820671 (Peptidomimetic protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/07, A61K38/08, A61K38/095, A61K38/21